CAMBRIDGE, Mass., Feb. 4 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation at the BIO CEO & Investor 2008 Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.
The presentation will include an overview of the Company, VELCADE(R) (bortezomib) for Injection, other product candidates and upcoming corporate events. The presentation will be delivered at 11:45 a.m. ET on Monday, February 11, 2007 from the Waldorf Astoria Hotel in New York, NY. The presentation will be archived for 30 days.
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.
Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.
|SOURCE Millennium Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved